Michael Linn
Impact in
-
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
-
- Neuroscience and Neuropharmacology Research
Papers in
-
- Neuroscience and Neuropharmacology Research 4
- Neurotransmitter Receptor Influence on Behavior 2
- Oncology 3
- Cancer-related Molecular Pathways 1
- Co-authors
- Kenneth Daniel Kolinsky (6 shared papers)Brian Higgins (5 shared papers)Kathryn E. Packman (5 shared papers)David C. Heimbrook (3 shared papers)Eric B. Wheeldon (2 shared papers)Melissa Laird Smith (2 shared papers)Kelli Glenn (2 shared papers)Gordon Beck (1 shared paper)
- Journals
- Cancer Chemotherapy and Pharmacology (2 papers)Addiction Biology (1 paper)Molecular Cancer Therapeutics (1 paper)Clinical Cancer Research (1 paper)The International Journal of Neuropsychopharmacology (1 paper)
- Partner nations
- United StatesSerbiaSwitzerland
In The Last Decade
Michael Linn
13 papers receiving 533 citations
Peers
Comparison fields: 5 of 56
- Oncology 143
- Cellular and Molecular Neuroscience 52
- Pulmonary and Respiratory Medicine 85
- Modeling and Simulation 11
- Molecular Biology 138
Countries citing papers authored by Michael Linn
This map shows the geographic impact of Michael Linn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Linn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Linn more than expected).
Fields of papers citing papers by Michael Linn
This network shows the impact of papers produced by Michael Linn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Linn. The network helps show where Michael Linn may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Linn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 168 | |
| 2 | 2004 | 131 | |
| 3 | 2014 | 59 | |
| 4 | 2009 | 48 | |
| 5 | 2006 | 43 | |
| 6 | Antitumor activity of capecitabine and bevacizumab combination in a human estrogen receptor-negative breast adenocarcinoma xenograft model. | 2007 | 23 |
| 7 | 2006 | 22 | |
| 8 | 2010 | 14 | |
| 9 | 2011 | 11 | |
| 10 | 2013 | 11 | |
| 11 | 2013 | 10 | |
| 12 | 2006 | 8 | |
| 13 | 2013 | 3 |
About Michael Linn
Michael Linn is a scholar working on Cellular and Molecular Neuroscience, Oncology, Molecular Biology, Complementary and alternative medicine and Cancer Research, having authored 13 papers that have together received 551 indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (4 papers), Angiogenesis and VEGF in Cancer (3 papers), Neurotransmitter Receptor Influence on Behavior (2 papers), Lung Cancer Treatments and Mutations (1 paper), Substance Abuse Treatment and Outcomes (1 paper), Alzheimer's disease research and treatments (1 paper), Cancer-related Molecular Pathways (1 paper) and Medicinal Plant Extracts Effects (1 paper). The work is most often cited by research in Oncology (143 citations), Cellular and Molecular Neuroscience (52 citations), Pulmonary and Respiratory Medicine (85 citations), Modeling and Simulation (11 citations) and Molecular Biology (138 citations). Michael Linn has collaborated with scholars based in United States, Serbia and Switzerland. Frequent co-authors include Kenneth Daniel Kolinsky, Brian Higgins, Kathryn E. Packman, David C. Heimbrook, Eric B. Wheeldon, Melissa Laird Smith, Kelli Glenn, Gordon Beck, Herbert Birnboeck and James Minton Cook. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, Addiction Biology, Molecular Cancer Therapeutics, Clinical Cancer Research and The International Journal of Neuropsychopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.